Patent · US Expired

Imidazonaphthyridines

US6514985B1 · kind B1 · utility

82Cited by
35References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 6, 2000
Grant dateFeb 4, 2003
Priority date
Expiry dateDec 7, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.